RESUMO
Introducción y desarrollo. Los protocolos de quimioterapiaen el tratamiento de los tumores cerebrales, como en los deotras localizaciones, emplean moléculas tóxicas para matar célulascancerosas. Pero, al igual que sucede con todos los tratamientoscontra el cáncer, la aparición de efectos secundarios y la ausenciade respuesta son los principales problemas para su eficacia.Su predicción va a ser posible gracias a los avances tecnológicosque se apoyan en la farmacogenómica y farmacoproteómica, dandolugar a la medicina personalizada. Sin embargo, todavía sonpocos los estudios que relacionan moléculas activas para el tratamientode tumores cerebrales y la posibilidad de predecir el porcentajede respuesta y de toxicidad. Conclusiones. El desarrollo denuevas tecnologías basadas en los microarrays de alta densidadestá logrando la identificación de genes cuya presencia permitirápredecir el efecto de determinado protocolo terapéutico. Una vezidentificados, equipos de arrays de baja densidad detectarán exclusivamentelos genes que pueden intervenir en la capacidad derespuesta del paciente y la posibilidad de presentar cuadros tóxicos.Otras técnicas sofisticadas en fase más experimental, que sebasan en el estudio de proteínas (proteómica), como las MALDI(Matrix-Assisted Laser Desorption Ionization) y las SELDI (Surface-Enhanced Laser Desorption Ionization), permitirán reconocerproteínas asociadas a la predicción de respuesta y de toxicidad
Introduction and development. Chemotherapy protocols for treatment of brain tumors use toxic molecules forkilling cancer cells in a similar way that protocols for treating other cancers. Therefore, secondary effects and poor responseare the major handicaps. Technological developments based on pharmacogenomics and pharmacoproteomics will predictresponse and toxicity giving rise to a personalized medicine. However, there are only few studies that correlate chemotherapeuticalmolecules for brain tumor treatment and prediction of response and toxicity. Conclusions. The development ofnew technologies based on high-density microarrays allows the progressive identification of genes whose presence will predictthe efficacy of therapeutic protocols. Once identified, specific equipments based on low-density arrays will detect exclusivelyin an easy and fast way the presence of genes in order to predict patients response and avoid toxicity. Other moresophisticated techniques at present still at an experimental step based on proteomics as MALDI (Matrix-Assisted LaserDesorption Ionization) and SELDI (Surface-Enhanced Laser Desorption Ionization) will allow the identification of proteinsthat could predict response and toxicity
Assuntos
Humanos , Protocolos Antineoplásicos , Farmacogenética , Proteômica/métodos , Neoplasias Encefálicas/terapiaRESUMO
Vascular endothelial growth factor (VEGF) is a major mediator in angiogenesis and vascular permeability. In central nervous system (CNS) it plays a pivotal role as: 1. inductor of endothelial cell proliferation, migration and inhibition of apoptosis, and 2. mediator of vascular permeability and subsequently of brain edema. This ubiquitous epiphenomenon is a major complication in several CNS pathologies, including head trauma and stroke. After brain injury the expression of VEGF is increased contributing to disruption of the blood brain barrier (BBB). VEGF increase the permeability of BBB via the synthesis/release of nitric oxide and subsequent activation of soluble guanylate cyclase. The immunohistochemistry shows an increase of stained astrocytes and endothelial cells around cortical micronecrosis. VEGF immunopositivity distribution shows some correspondence with the blood brain barrier breakdown following a cortical micronecrosis.
Assuntos
Barreira Hematoencefálica/fisiologia , Córtex Cerebral/patologia , Necrose , Fator A de Crescimento do Endotélio Vascular/metabolismo , Animais , Córtex Cerebral/citologia , Córtex Cerebral/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de TempoRESUMO
Corms of Crocus sativus L. (Iridaceae) contain a glycoconjugate that shows cytotoxic activity on tumoral cells in culture. Studies of intracellular calcium fluctuations, and release of lactate dehydrogenase in human cervical epitheloid carcinoma cells, showed that this compound caused plasma membrane damage, allowing movements of both calcium and macromolecules, and leading to cell lysis. Analysis of DNA fragmentation showed that cell death was not mediated by apoptosis. This molecule is active against human tumoral cells derived from fibrosarcoma, cervical epithelioid carcinoma and breast carcinoma, with IC50 values of 7, 9 and 22 micrograms/ml, respectively. The proteoglycan is about 8 times more cytotoxic for malignant cells than for their normal counterparts. In addition, 100 micrograms/ml of proteoglycan produced 50% in vitro lysis of normal human erythrocytes, whereas 320 micrograms/ml induced about 60% cell death on cultured human hair follicles. Altogether, these results suggests a distinctive cytotoxic activity of this molecule on different human cell types.
Assuntos
Antineoplásicos Fitogênicos/farmacologia , Glicoconjugados/farmacologia , Plantas Medicinais/química , Humanos , Células Tumorais CultivadasRESUMO
Saffron corms contain a proteoglycan that is highly cytotoxic on human tumor cells. The present work was undertaken to study the possible immunomodulatory and anti-invasive properties of this compound. Non-cytotoxic concentrations of this glycoconjugate promoted significant macrophage activation, detected by the release of nitric oxide. A rapid activation of protein kinase C and NF-kappaB was obtained after proteoglycan treatment, which could explain the induction of nitric oxide synthase. Proteoglycan concentrations ranging from 10-1000 ng/ml specifically promoted apoptosis of macrophages, probably triggered by their activation. This molecule did not inhibit in vitro migration or invasion of human tumor cells. Altogether these results support a plausible immuno-modulating activity for this saffron Crocus compound.
Assuntos
Adjuvantes Imunológicos/farmacologia , Liliaceae/química , Ativação de Macrófagos/efeitos dos fármacos , Proteoglicanas/farmacologia , Apoptose/efeitos dos fármacos , Movimento Celular/efeitos dos fármacos , Humanos , NF-kappa B/metabolismo , Óxido Nítrico/biossíntese , Óxido Nítrico Sintase/biossíntese , Óxido Nítrico Sintase Tipo II , Proteína Quinase C/fisiologia , Células Tumorais CultivadasRESUMO
We used an experimental model in the rat to examine the effects of long-term treatment with crocin, a glycosylated carotenoid from the stigmas of the saffron crocus, on colon cancer. BD-IX rats were divided into four groups: Groups G1 and G2, designated "cancer groups," were used to study the effects of crocin on the progression of colon cancer, and Groups G3 and G4, designated "toxicity groups," were used to study the effects of the treatment on metabolic processes and the parenchyma. DHD/K12-PROb cells were injected subcutaneously into the chest of Group G1 and G2 animals. From 1 to 13 weeks after inoculation, animals in Groups G2 and G4 received a weekly injection of crocin (400 mg/kg body wt s.c.). Animals in Groups G1 and G3 received no treatment. In addition, lines of animal and human colon adenocarcinoma cells (DHD/K12-PROb and HT-29) were used to perform assays in vitro to examine the cytotoxicity of crocin. Life span was extended and tumor growth was slower in crocin-treated female rats, but no significant antitumor effect was found in male rats. Acute tubular necrosis was found in all kidney samples from crocin-treated animals, but slight signs of nephrotoxicity were found by biochemical analysis of the serum. In assays in vitro, crocin had a potent cytotoxic effect on human and animal adenocarcinoma cells (HT-29 and DHD/K12-PROb cells, 50% lethal dose = 0.4 and 1.0 mM, respectively). Treated cells exhibited a remarkable loss of cytoplasm and wide cytoplasmic vacuole-like areas. In conclusion, long-term treatment with crocin enhances survival selectively in female rats with colon cancer without major toxic effects. The effects of crocin might be related to its strong cytotoxic effect on cultured tumor cells.
Assuntos
Adenocarcinoma/tratamento farmacológico , Carotenoides/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Liliaceae/química , Adenocarcinoma/patologia , Animais , Carotenoides/efeitos adversos , Sobrevivência Celular/efeitos dos fármacos , Neoplasias do Colo/patologia , Feminino , Humanos , Nefropatias/induzido quimicamente , Túbulos Renais/patologia , Masculino , Necrose , Transplante de Neoplasias , Ratos , Células Tumorais CultivadasRESUMO
The v-erbA oncogene coding for a mutated form of the thyroid hormone (T3) receptor (TR alpha 1) increased the invasion capacity of the mouse B3.1 glial cell line. This effect was mediated by the induction of platelet-derived growth factor (c-sis/PDGF B), as shown by its inhibition using an anti-PDGF BB antibody. Also, the low invasion capacity of parental B3.1 and c-erbA-expressing cells (B3.1 + TR alpha 1) was enhanced by exogenously added PDGF BB. This effect was independent of the growth-promoting activity of PDGF and unrelated to the secretion of metalloproteinases. All three cell types (parental B3.1, B3.1 + v-erbA, and B3.1 + TR alpha 1) secreted similar high levels of the M(r) 72,000 collagenase IV (A) independently of PDGF. Anchorage-independent cell growth was also enhanced by v-erbA; B3.1 + v-erbA cells but neither parental B3.1 nor B3.1 + TR alpha 1 cells formed foci in soft agar. The effect of v-erbA only happened in the presence of serum, suggesting that some serum factor(s) cooperate with PDGF to overcome the anchorage dependence of B3.1 + v-erbA cells. Supporting this, high doses of exogenous PDGF were much less efficient than serum, and the addition of an anti-PDGF BB antibody blocked only partially the effect of serum. Basic fibroblast growth factor was found to cooperate with PDGF to abolish anchorage dependence. Moreover, B3.1 + v-erbA cells detached and grew in suspension when cultured on plastic dishes. Interestingly, the transformation-competent c-jun and fra-1 oncogenes were induced by v-erbA in serum-free medium and are candidates to mediate v-erbA effects. In summary, our results show that v-erbA induces transformation parameters in the glial B3.1 cell line via an increase in c-sis/PDGF B and probably other mechanisms, suggesting a role for (autocrine) PDGF stimulation in glial cell transformation.
Assuntos
Transformação Celular Neoplásica , Genes erbA/fisiologia , Neuroglia/citologia , Fator de Crescimento Derivado de Plaquetas/fisiologia , Proteínas Proto-Oncogênicas/fisiologia , Animais , Becaplermina , Sangue , Adesão Celular , Contagem de Células , Divisão Celular , Linhagem Celular , Colagenases/biossíntese , Fator 2 de Crescimento de Fibroblastos/farmacologia , Genes jun/genética , Camundongos , Invasividade Neoplásica , Neuroglia/patologia , Fator de Crescimento Derivado de Plaquetas/farmacologia , Proteínas Proto-Oncogênicas c-fos/genética , Proteínas Proto-Oncogênicas c-sis , RNA Mensageiro/análise , Receptores dos Hormônios Tireóideos/genética , Tri-IodotironinaRESUMO
We have developed a modified chemotaxis chamber assay in which bovine aortic endothelial (BAE) cells degrade Matrigel basement membrane and migrate and form capillary-like structures on type I collagen. This capillary formation occurs in the presence of conditioned media from highly metastatic tumour cell lines, such as B16F10 murine melanoma or MDA-MD-231 human breast adenocarcinoma, but not in the presence of conditioned medium (CM) from the less invasive B16F0 cell line. Replacement of tumour cell CM by 10 ng ml-1 basic fibroblast growth factor (bFGF) also results in capillary-like structure formation by BAE cells. An anti-bFGF antibody blocks this effect, showing that bFGF is one of the factors responsible for the angiogenic response induced by B16F10 CM in our assay. Addition of an anti-laminin antibody reduces significantly the formation of capillary-like structures, probably by blocking the attachment of BAE cells to laminin present in Matrigel. The anti-angiogenic compound suramin inhibits in a dose-dependent manner (complete inhibition with 100 microM suramin) the migration and differentiation of BAE cells on type I collagen in response to B16F10 CM. This assay represents a new model system to study tumour-induced angiogenesis in vitro.
Assuntos
Adenocarcinoma/fisiopatologia , Neoplasias da Mama/fisiopatologia , Capilares/citologia , Diferenciação Celular , Quimiotaxia , Endotélio Vascular/citologia , Melanoma Experimental/fisiopatologia , Neovascularização Patológica , Adenocarcinoma/patologia , Animais , Anticorpos/farmacologia , Aorta , Neoplasias da Mama/patologia , Bovinos , Células Cultivadas , Meios de Cultivo Condicionados , Fator 2 de Crescimento de Fibroblastos/farmacologia , Humanos , Laminina/imunologia , Laminina/farmacologia , Melanoma Experimental/patologia , Camundongos , Camundongos Endogâmicos , Invasividade Neoplásica , Suramina/farmacologia , Células Tumorais CultivadasRESUMO
Increased type III collagen deposition in all layers of the intestinal tract, including the lamina propria, is a common feature of strictures in Crohn's disease. In the present study, it was found that in comparison with fibroblasts from normal or nonstrictured but inflamed intestinal lamina propria, the fibroblasts isolated from strictures of patients with Crohn's disease produce significantly more collagen, especially collagen type III. Transforming growth factor beta 1 (TGF-beta 1) significantly increased collagen type III synthesis in intestinal lamina propria fibroblasts isolated from all patients. The effect of TGF-beta 1 on type III collagen synthesis in fibroblasts from strictures in Crohn's disease was significantly higher than that in fibroblasts from inflamed specimens of the same patients. In contrast, platelet-derived growth factor decreased collagen type III synthesis in lamina propria fibroblasts derived from strictures compared with fibroblasts from nonstrictured but inflamed tissue. These findings indicate that fibroblasts in the lamina propria of patients with Crohn's disease have a different reactivity towards cytokines. On the basis of increased type III collagen deposition in intestinal strictures of Crohn's disease by using cell adhesion and cell proliferation assays, it was shown that collagen type III stimulated adhesion and proliferation of lamina propria fibroblasts. The current data provide evidence that the different reactivity of mesenchymal cells to cytokines in terms of synthesizing type III collagen fibrils, which is a major component of collagen fibrils, may play an important role in the pathogenesis of fibrosis and stricture formation in chronic inflammatory bowel diseases.
Assuntos
Colágeno/biossíntese , Doença de Crohn/metabolismo , Mucosa Intestinal/metabolismo , Adulto , Adesão Celular , Divisão Celular , Células Cultivadas , Colágeno/análise , Doença de Crohn/patologia , Citocinas/farmacologia , Feminino , Fibroblastos/metabolismo , Humanos , Intestinos/patologia , Masculino , Pessoa de Meia-Idade , Pró-Colágeno/biossíntese , Biossíntese de ProteínasRESUMO
The adhesive properties of tumour cells to laminin, the major glycoprotein of basement membranes, play a crucial part in the complex process of tumour invasion and metastasis. We therefore investigated the expression of laminin binding proteins in isolated basolateral cell membranes of human colorectal carcinomas and the adjacent normal colonic mucosa. Cell membrane binding assays and immunoblotting experiments showed appreciable quantitative and qualitative differences in the expression of these proteins in neoplastic and normal tissue. Epithelial basolateral cell membranes of colorectal carcinomas bound five to eight times more radioactive labelled laminin than basolateral cell membranes of the adjacent normal colonic epithelium. The expression of laminin binding proteins with Mr 66,000-69,000 daltons corresponding to the so called 'Mr 67,000 dalton laminin receptor' was three to four times higher in colorectal carcinomas than in normal colonic epithelium. In addition, laminin binding proteins with higher molecular weights, which may be related to the family of integrins, were also increased in colorectal carcinomas. In particular, laminin binding proteins with Mr 180,000 daltons were exclusively expressed on neoplastic epithelial cells of human colorectal carcinomas. Our data suggest that certain classes of laminin binding proteins may be selectively expressed on colonic tumour cells, leading to an increased capacity for migration, invasion, and metastasis.
Assuntos
Proteínas de Transporte/análise , Colo/química , Neoplasias Colorretais/química , Laminina/análise , Membrana Celular/química , Eletroforese em Gel de Poliacrilamida , Humanos , Immunoblotting , Mucosa Intestinal/química , Peso MolecularRESUMO
The urea extract of the glycoproteins from the extracellular matrix of rat liver has been compared with that of Morris hepatoma 7777. A high molecular weight glycoprotein present in Morris hepatoma 7777 was not found in the extract of liver matrix. Under reducing conditions in SDS-gel electrophoresis this component gave two glycoprotein bands with Mr 53 k and 56 k. The indirect immunofluorescence staining with a monospecific antiserum directed against the component showed its abundant presence in Morris hepatoma 7777 as well as in the less malignant Morris hepatoma 9121 in form of extracellular network structures. The antigen also densely filled some cumuli of cells. In contrast the liver tissue showed only very weak staining of the extracellular areas. The overall distribution of the component could be correlated with the distribution of several hydrolases in the tumor matrix, notably beta-D-glucuronidase.